Align Technology, Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
ALGN
Clean balance sheet with low leverage (0.0× debt-to-equity).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $209.00 (+16.8%)
14 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
ALGN
PFE
30.0×
Trailing P/E
19.4×
14.5×
Forward P/E
9.4×
10.5%
Profit Margin
12.4%
70.5%
Gross Margin
75.8%
10.8%
ROE
8.9%
6.2%
Revenue Growth
-1.2%
23.9%
Earnings Growth
—
1.81
Beta
0.39
—
Price / Book
—
$12.8B
Market Cap
$149.8B
$122 – $208
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →